Purchase Order 75F40124P00112
- Not listed
- This is a $190,019.00 firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) and Center for Food Safety and Applied Nutrition (CFSAN) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for an on-site preventative maintenance service agreement for Molecular Devices' Image-Xpress Confocal HT.AI high-content screening system. The contract has an ultimate completion date of September 29, 2027. Molecular Devices is a for-profit limited...
- This firm fixed price purchase order from the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to Molecular Devices LLC is valued at seventy-three thousand three hundred seventy-four dollars ($73,374) to upgrade an existing ImageXpress Micro Confocal High Content Imaging System (IXMC). The upgrade will include an automated water immersion unit and a 40x Apo LWD 1.15 NA water immersion objective, as requested in the combined synopsis and solicitation to meet the...
- This federal contract award, valued at $16,520.00, was issued by the Food and Drug Administration (FDA) to Molecular Devices LLC, a for-profit limited liability company based in San Jose, California. The contract is for preventive maintenance services on the FLIPR TETRA system, which is a specialized scientific instrument used for high-throughput cellular screening and drug discovery applications. The contract is a firm-fixed-price purchase order with no set-aside designation. Molecular...
- The Food and Drug Administration awarded a $1.02M firm fixed-price purchase order to Molecular Devices LLC on July 23, 2020, for robotic arm replacement on CLONEPIX2 equipment. The contract, which carries no set-aside designation, was performed in Silver Spring, Maryland, with an ultimate completion date of September 2, 2024. Molecular Devices LLC, a San Jose-based subsidiary of Danaher Corporation, is a leading manufacturer of advanced bioanalytical measurement solutions and specialized...
- The Food and Drug Administration awarded a $22.9K firm fixed price purchase order to Molecular Devices LLC for preventative maintenance and repair services on a SpectraMax M2E microplate cuvette reader (Serial #DE05277) located in Silver Spring, Maryland. The contract, awarded on July 22, 2019, with a completion date of July 21, 2021, carries no set-aside designation, reflecting competitive procurement practices. Molecular Devices LLC, a San Jose, California-based subsidiary of Danaher...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract, valued at $24,946.00, is for a "Service Plan on a Fluorescent Imaging Plate Reader." The contract has no set-aside designation. Molecular Devices LLC is a for-profit limited liability company that specializes in providing high-performance bioanalytical measurement solutions, including sophisticated laboratory...
- The Department of Health and Human Services Food and Drug Administration has awarded a Firm Fixed Price purchase order to Molecular Devices LLC, a subsidiary of Danaher Corporation, for a CONFOCAL UPGRADE. The $189,000.00 contract has an August 15, 2023 completion date and was awarded on August 16, 2022. Molecular Devices is a provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company has previously received federal...
- The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed price purchase order contract worth $249,210.00 to Molecular Devices LLC, a subsidiary of Danaher Corporation, for an ImageXpress Micro 4 High Content Screening System. The system is intended to enable the FDA's National Center for Toxicological Research to perform measurements of intracellular calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes to better understand the mechanisms...
- This contract modification, awarded to Molecular Devices LLC on March 8, 2021, represents a de-obligation and closeout of a purchase order for multi-detection microplate reader onsite preventive maintenance and calibration services. The contract, valued at $15,432.00 under a firm fixed-price arrangement, was funded by the Food and Drug Administration (FDA) for performance in San Jose, California, where the contractor is headquartered. No small business set-aside designation was used for this...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a division of Danaher Corporation, for maintenance services for an image processing system. The contract has a ceiling value of $17,807.00 and a completion date of July 31, 2023. Molecular Devices LLC is the original equipment manufacturer and a frequent provider of bioanalytical instruments, equipment, and related services to various federal agencies, including the...
The Food and Drug Administration awarded a $41,309.15 firm fixed price purchase order to Molecular Devices LLC for preventative maintenance and unlimited repair services on a Molecular Devices ImageXpress Micro Confocal High Content Imaging System. The contract, awarded July 1, 2024, with an ultimate completion date of June 30, 2025, was issued without a set-aside designation. Services will be performed at the National Center for Toxicological Research facility in Jefferson, Arkansas, and include annual preventative maintenance visits with replacement parts, 48-hour repair response times, and unlimited technical support including software and firmware updates. Molecular Devices LLC, a subsidiary of Danaher Corporation headquartered in San Jose, California, specializes in advanced bioanalytical measurement solutions and has an established track record providing scientific instruments and related services to federal agencies. This award represents a modification to the original contract to cancel non-funded option years 2, 3, 4, and 5 and close out the contract, effectively limiting performance to the base period. The ImageXpress Micro Confocal system is a high-content imaging platform critical to the FDA's toxicological research and drug safety evaluation capabilities. As the original equipment manufacturer with proprietary technology, Molecular Devices was awarded this contract on a non-competitive basis, consistent with the company's typical federal procurement arrangements for specialized scientific equipment maintenance and support services.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Preventative Maintenance (PM) and unlimited repair service contract on a (Molecular Devices) ImageXpress Micro Confocal (IXMC) High Content Imaging System | 75F40124SSN121437 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Pre-Solicitation 1/2 | 1/3/24, 2:12 PM | |
Preventative Maintenance (PM) and unlimited repair service contract on a (Molecular Devices) ImageXpress Micro Confocal (IXMC) High Content Imaging System | 75F40124Q121437 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 2/2 | 1/26/24, 1:13 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | $0 | 1/29/26 | |
| Not listed | Not listed | $41.3k | 6/20/24 |